Insider Transactions in Q2 2025 at Boston Scientific Corp (BSX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
56,372
-24.02%
|
$5,749,944
$102.88 P/Share
|
|
Jun 04
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
56,372
+19.37%
|
$1,465,672
$26.15 P/Share
|
|
Jun 02
2025
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
164,443
-5.14%
|
$16,937,629
$103.72 P/Share
|
|
Jun 02
2025
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
105,619
+3.17%
|
$2,112,380
$20.91 P/Share
|
|
May 29
2025
|
Edward J Ludwig Director |
SELL
Open market or private sale
|
Direct |
4,000
-15.11%
|
$416,000
$104.59 P/Share
|
|
May 21
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Open market or private sale
|
Direct |
4,826
-13.33%
|
$511,556
$106.42 P/Share
|
|
May 08
2025
|
John E Sununu Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,081
+3.66%
|
-
|
|
May 08
2025
|
David S Wichmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,081
+4.77%
|
-
|
|
May 08
2025
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,081
+5.32%
|
-
|
|
May 08
2025
|
Yoshiaki Fujimori Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,081
+29.46%
|
-
|
|
May 08
2025
|
David C Habiger Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,081
+26.99%
|
-
|
|
May 08
2025
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,081
+7.29%
|
-
|
|
May 08
2025
|
Jessica L Mega Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,081
+20.17%
|
-
|
|
May 08
2025
|
Susan E Morano Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,686
+17.0%
|
-
|
|
May 05
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
4,572
-19.64%
|
$475,488
$104.54 P/Share
|
|
May 02
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,017
-4.18%
|
$105,768
$104.93 P/Share
|
|
May 02
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,102
+7.95%
|
-
|
|
May 02
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,918
-7.61%
|
$199,472
$104.93 P/Share
|
|
May 02
2025
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,204
+14.3%
|
-
|
|
May 01
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
17,314
-43.78%
|
$1,766,028
$102.06 P/Share
|
|
May 01
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
17,314
+11.05%
|
$380,908
$22.9 P/Share
|
|
May 01
2025
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
164,443
-4.96%
|
$16,773,186
$102.52 P/Share
|
|
May 01
2025
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
105,619
+3.06%
|
$2,112,380
$20.91 P/Share
|
|
Apr 21
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Open market or private sale
|
Direct |
4,826
-11.77%
|
$458,470
$95.09 P/Share
|
|
Apr 01
2025
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
164,442
-9.35%
|
$16,444,200
$100.01 P/Share
|
|
Apr 01
2025
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
105,618
+2.96%
|
$2,112,360
$20.91 P/Share
|